Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Kirby Daniel Gordon exercised options for 10,001 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 12, 2026

On Aug 10, 2026, Kirby Daniel Gordon (Chief Commercial Officer) exercised options for 10,001 Iovance Biotherapeutics, Inc. shares, leaving 154,511 shares. Filed Aug 12, 2026 (Form 4).

Options exercised
10,001 shares
Holding after
154,511 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockOption exercise10,001156,947Direct
Aug 10, 2026Common StockShares withheld for tax2,436US$6.40154,511Direct

Source

View original at SEC

Related